Skip to main content
SpringerLink
Log in

Health Canada has updated the labelling for Avelox [moxifloxacin]

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Health Canada.Updated Labelling for Antibiotic Avelox (Moxifloxacin) Regarding Rare Risk of Severe Liver Injury. Media Release: 22 Mar 2010. Available from: URL: http://www.hc-sc.gc.ca

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Health Canada has updated the labelling for Avelox [moxifloxacin]. React. Wkly. 1294, 2 (2010). https://doi.org/10.2165/00128415-201012940-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201012940-00005

Keywords

Search

Navigation